Fujian Haixi Pharmaceuticals Co., Ltd. (HKG:2637)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
136.50
+0.50 (0.37%)
At close: Feb 13, 2026

HKG:2637 Revenue

In the year 2024, Fujian Haixi Pharmaceuticals had annual revenue of 466.68M CNY with 47.39% growth.

Revenue
466.68M CNY
Revenue Growth
+47.39%
P/S Ratio
21.63
Revenue / Employee
2.85M CNY
Employees
164
Market Cap
10.74B HKD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024466.68M150.05M47.39%
Dec 31, 2023316.63M104.17M49.03%
Dec 31, 2022212.47M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition